Digital Cytometry of Mixed Cell Populations Without Cell Sorting

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Comprehensive assessment of cellular heterogeneity in tissues is challenging due to the complexity of cell types and the lack of effective methods for studying tissue composition without physical dissociation or prior knowledge.

Innovation Solution

A computational framework, CIBERSORTx, is used to infer cell type abundance and gene expression from RNA profiles of intact tissues using single-cell experiments or sorted cell subsets, enabling digital purification of cell types from bulk RNA admixtures through techniques like cross-platform data normalization and in silico cell purification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If physical dissociation or cell sorting methods are used to study tissue composition, then cell type identification accuracy is improved, but tissue integrity and sample complexity are worsened

Engineering Contradiction:
Improvecell type identification accuracyVSAvoidsample processing complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces physical/mechanical cell separation methods (dissociation, sorting) with a computational/mathematical approach. The deconvolution algorithm mathematically separates bulk tissue gene expression profiles into constituent cell type proportions and signatures, eliminating the need for physical manipulation of cells while maintaining identification accuracy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces a computational intermediary (the deconvolution algorithm and reference signatures) that mediates between the bulk tissue RNA input and the cell type composition output. This computational layer enables indirect separation and identification of cell types without direct physical intervention.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Stability of the object's composition

If bulk RNA sequencing is performed on intact tissues, then sample integrity is maintained, but cell type-specific gene expression resolution is reduced

Engineering Contradiction:
Improvetissue integrityVSAvoidcell type-specific gene expression resolution
Core Design Contradiction:
Stability of the object's compositionVSMeasurement precision

Solution Approach 1:

The patent applies computational segmentation by decomposing the bulk tissue gene expression profile into distinct cell type-specific components. The deconvolution algorithm segments the mixed signal into individual cell type contributions, enabling resolution of cell type-specific expression while the physical tissue remains intact.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the analytical parameter from direct physical measurement of individual cells to mathematical deconvolution of bulk signals. By transforming the problem from spatial/physical separation to computational parameter optimization, the method achieves cell type resolution without compromising tissue integrity.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If traditional cell separation methods are used, then cell type purity is improved, but time consumption and procedural complexity increase

Engineering Contradiction:
Improvecell type purityVSAvoidprocessing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces time-consuming mechanical cell separation procedures with rapid computational analysis. The in silico deconvolution process achieves cell type purification in silico without the hours or days required for physical sorting, isolation, and validation methods.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent uses pre-established reference cell type signatures as a foundation for the deconvolution analysis. These reference profiles are prepared in advance, enabling the bulk tissue analysis to proceed rapidly by comparing against known signatures rather than requiring de novo cell separation and characterization.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS12562239B2Systems and methods for analyzing mixed cell populations
Publication Date: 2026.02.24 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US12562239B2 patent drawing
  • US12562239B2 patent drawing
  • US12562239B2 patent drawing

AI summary

The present disclosure provides systems and methods for analyzing a mixed population of cells. In particular, the present disclosure provides systems and methods for digital cytometry of a biological sample, digital analysis of a biological sample, digital purification of a biological sample, evaluation of a disease in an individual, and prediction of a clinical outcome of a disease therapy.